IFNB1 and systemic lupus erythematosus: In an effort to elucidate the Co-IR expression discrepancy found in our study, we applied exogenous IFN-β together with or without the JAK inhibitor Tofacitinib to the PMBC cultures obtained from LN- (n = 3) and LN + (n = 4) SLE patients.